Nektar TherapeuticsNektar TherapeuticsNektar Therapeutics

Nektar Therapeutics

No trades
See on Supercharts

Price target

3.580.000.00%
The 4 analysts offering 1 year price forecasts for NKTR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to NKTR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NKTR EPS for the last quarter is −0.18 USD despite the estimation of −0.20 USD. In the next quarter EPS is expected to reach −0.16 USD. Track more of Nektar Therapeutics financials and stay on top of what is up with the company.
In the next quarter Nektar Therapeutics revenue is expected to reach ‪29.81 M‬ USD. Check out Nektar Therapeutics revenue and earnings and make informed decisions.
According to analysts, NKTR price target is 3.58 USD with a max estimate of 7.00 USD and a min estimate of 1.30 USD. Check if this forecast comes true in a year, meanwhile watch Nektar Therapeutics stock price chart and keep track of the current situation with NKTR news and stock market news.
We've gathered opinions of 7 analysts rating NKTR stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.